Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/231294 |
Resumo: | Obesity treatments, such as calorie restriction (CR), eventually lead to muscle wasting and higher rates of neuroinflammation, whereas hypothalamic inflammatory conditions impair body weight (BW) control. Nicotinamide riboside (NR) has been proposed against obesity but with little evidence on skeletal muscle tissue (SMT) and neuroinflammation. Therefore, we aimed to investigate the effects of CR on SMT and on hypothalamic inflammatory biomarkers in obese adult male Wistar rats, and whether NR supplementation alone or in combination with CR affects these parameters. Obesity was induced in rats through a cafeteria diet for 6 weeks. After that, a group of obese rats was exposed to CR, associated or not associated with NR supplementation (400 mg/kg), for another 4 weeks. As a result, obese rats, with or without CR, presented lower relative weight of SMT when compared with eutrophic rats. Rats under CR presented lower absolute SMT weight compared with obese and eutrophic rats, in addition to presenting elevated hypothalamic levels of TNF-α. NR supplementation, in all groups, enhanced weight loss and increased relative weight of the SMT. Furthermore, in animals under CR, NR reversed increases TNF-α levels in the hypothalamus. In this study, these data, although succinct, are the first to evidence the effects of NR on SMT and neuroinflammation when associated with CR, especially in obesity conditions. Therefore, this provides preliminary support for future studies in this investigative field. Furthermore, NR emerges as a potential adjuvant for preventing muscle mass loss in the weight loss processes. |
id |
UFRGS-2_bfe6d7546588220b55abb6467529b8d5 |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/231294 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Castro, Josimar Macedo deStein, Dirson JoãoMedeiros, Helouise RichardtOliveira, Carla deTorres, Iraci Lucena da Silva2021-10-27T04:26:05Z20212296-861Xhttp://hdl.handle.net/10183/231294001132857Obesity treatments, such as calorie restriction (CR), eventually lead to muscle wasting and higher rates of neuroinflammation, whereas hypothalamic inflammatory conditions impair body weight (BW) control. Nicotinamide riboside (NR) has been proposed against obesity but with little evidence on skeletal muscle tissue (SMT) and neuroinflammation. Therefore, we aimed to investigate the effects of CR on SMT and on hypothalamic inflammatory biomarkers in obese adult male Wistar rats, and whether NR supplementation alone or in combination with CR affects these parameters. Obesity was induced in rats through a cafeteria diet for 6 weeks. After that, a group of obese rats was exposed to CR, associated or not associated with NR supplementation (400 mg/kg), for another 4 weeks. As a result, obese rats, with or without CR, presented lower relative weight of SMT when compared with eutrophic rats. Rats under CR presented lower absolute SMT weight compared with obese and eutrophic rats, in addition to presenting elevated hypothalamic levels of TNF-α. NR supplementation, in all groups, enhanced weight loss and increased relative weight of the SMT. Furthermore, in animals under CR, NR reversed increases TNF-α levels in the hypothalamus. In this study, these data, although succinct, are the first to evidence the effects of NR on SMT and neuroinflammation when associated with CR, especially in obesity conditions. Therefore, this provides preliminary support for future studies in this investigative field. Furthermore, NR emerges as a potential adjuvant for preventing muscle mass loss in the weight loss processes.application/pdfengFrontiers in nutrition. Lausanne. vol. 8 (2021), 648893, 8 f.NiacinamidaRestrição calóricaMúsculosObesidadeNicotinamide ribosideCaloric restrictionObesityNeuroinflammationMuscle massSkeletal muscle tissueHypothalamusBrainNicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigationEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001132857.pdf.txt001132857.pdf.txtExtracted Texttext/plain40872http://www.lume.ufrgs.br/bitstream/10183/231294/2/001132857.pdf.txt88934c5cdfdbaf87d554c977e4064bb5MD52ORIGINAL001132857.pdfTexto completo (inglês)application/pdf932764http://www.lume.ufrgs.br/bitstream/10183/231294/1/001132857.pdf0d081c1b074ffbe714c62b0dbeeb4af0MD5110183/2312942021-11-20 05:54:36.746357oai:www.lume.ufrgs.br:10183/231294Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2021-11-20T07:54:36Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation |
title |
Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation |
spellingShingle |
Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation Castro, Josimar Macedo de Niacinamida Restrição calórica Músculos Obesidade Nicotinamide riboside Caloric restriction Obesity Neuroinflammation Muscle mass Skeletal muscle tissue Hypothalamus Brain |
title_short |
Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation |
title_full |
Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation |
title_fullStr |
Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation |
title_full_unstemmed |
Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation |
title_sort |
Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation |
author |
Castro, Josimar Macedo de |
author_facet |
Castro, Josimar Macedo de Stein, Dirson João Medeiros, Helouise Richardt Oliveira, Carla de Torres, Iraci Lucena da Silva |
author_role |
author |
author2 |
Stein, Dirson João Medeiros, Helouise Richardt Oliveira, Carla de Torres, Iraci Lucena da Silva |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Castro, Josimar Macedo de Stein, Dirson João Medeiros, Helouise Richardt Oliveira, Carla de Torres, Iraci Lucena da Silva |
dc.subject.por.fl_str_mv |
Niacinamida Restrição calórica Músculos Obesidade |
topic |
Niacinamida Restrição calórica Músculos Obesidade Nicotinamide riboside Caloric restriction Obesity Neuroinflammation Muscle mass Skeletal muscle tissue Hypothalamus Brain |
dc.subject.eng.fl_str_mv |
Nicotinamide riboside Caloric restriction Obesity Neuroinflammation Muscle mass Skeletal muscle tissue Hypothalamus Brain |
description |
Obesity treatments, such as calorie restriction (CR), eventually lead to muscle wasting and higher rates of neuroinflammation, whereas hypothalamic inflammatory conditions impair body weight (BW) control. Nicotinamide riboside (NR) has been proposed against obesity but with little evidence on skeletal muscle tissue (SMT) and neuroinflammation. Therefore, we aimed to investigate the effects of CR on SMT and on hypothalamic inflammatory biomarkers in obese adult male Wistar rats, and whether NR supplementation alone or in combination with CR affects these parameters. Obesity was induced in rats through a cafeteria diet for 6 weeks. After that, a group of obese rats was exposed to CR, associated or not associated with NR supplementation (400 mg/kg), for another 4 weeks. As a result, obese rats, with or without CR, presented lower relative weight of SMT when compared with eutrophic rats. Rats under CR presented lower absolute SMT weight compared with obese and eutrophic rats, in addition to presenting elevated hypothalamic levels of TNF-α. NR supplementation, in all groups, enhanced weight loss and increased relative weight of the SMT. Furthermore, in animals under CR, NR reversed increases TNF-α levels in the hypothalamus. In this study, these data, although succinct, are the first to evidence the effects of NR on SMT and neuroinflammation when associated with CR, especially in obesity conditions. Therefore, this provides preliminary support for future studies in this investigative field. Furthermore, NR emerges as a potential adjuvant for preventing muscle mass loss in the weight loss processes. |
publishDate |
2021 |
dc.date.accessioned.fl_str_mv |
2021-10-27T04:26:05Z |
dc.date.issued.fl_str_mv |
2021 |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/231294 |
dc.identifier.issn.pt_BR.fl_str_mv |
2296-861X |
dc.identifier.nrb.pt_BR.fl_str_mv |
001132857 |
identifier_str_mv |
2296-861X 001132857 |
url |
http://hdl.handle.net/10183/231294 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Frontiers in nutrition. Lausanne. vol. 8 (2021), 648893, 8 f. |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/231294/2/001132857.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/231294/1/001132857.pdf |
bitstream.checksum.fl_str_mv |
88934c5cdfdbaf87d554c977e4064bb5 0d081c1b074ffbe714c62b0dbeeb4af0 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1815447772040527872 |